AKT crystal structure and AKT-specific inhibitors
Authors:
- 14 November 2005
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 24 (50) , 7493-7501
Abstract
AKT kinases are attractive targets for small molecule drug discovery because of their key role in tumor cell survival/proliferation and their overexpression/activation in many human cancers. This review summarizes studies that support the rationale for targeting AKT kinases in new drug discovery efforts. Structural features of AKT kinase in its inactive and active states, as determined by crystal structure analysis, are described. Recent efforts in the development and biological evaluation of small molecule inhibitors of AKT, and the challenges remaining are summarized. Inhibitors targeting the ATP binding site, PH domain and protein substrate binding site, as well as isoform selective allosteric inhibitors are reviewed. Structure-based design using PKA mutants as surrogates and computer modeling in the discovery of selective inhibitors is discussed. The issues and challenges facing the development of different classes of inhibitors as therapeutics are also discussed.Keywords
This publication has 40 references indexed in Scilit:
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- Proapoptotic Activity of Cell-Permeable Anti-Akt Single-Chain AntibodiesCancer Research, 2005
- Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Different inhibitory effect of imatinib on phosphorylation of mitogen‐activated protein kinase and Akt and on proliferation in cells expressing different types of mutant platelet‐derived growth factor receptor‐αInternational Journal of Cancer, 2004
- Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivoGene Therapy, 2003
- Regulation of protein kinases in insulin, growth factor and Wnt signallingCurrent Opinion in Structural Biology, 2002
- Crystal structure of an activated Akt/Protein Kinase B ternary complex with GSK3-peptide and AMP-PNPNature Structural & Molecular Biology, 2002
- Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase‐1 and p70 S6 kinaseFEBS Letters, 1996